908 Devices Inc.
NASDAQ:MASSMedical - Devices
+$0.22 today
- Market cap
- $395.86M
- Beta
- 0.64
- P/E (TTM)
- -9.0
- EPS (TTM)
- -$0.97
Volume 0.25M
Average 0.27M
MASS Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
908 Devices Inc.NASDAQ: MASS
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue growth accelerates
Q1 FY2026 revenue of $13.38M rose 13.6% year over year, ahead of the +2.2% change in trailing-twelve-month revenue. Sequentially, it fell 23.0% from the prior quarter. Over 3 fiscal years it compounded at +6.2% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether revenue reaches the consensus estimate from 5 analysts of $69.2M (+23.1%) for the fiscal year ending Dec 2026, a step up from the -5.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $13.38M-23.0% QoQ
- Last fiscal yearDec 2025
- $56.2M-5.8% YoY
- LTMMar 2026
- $57.8M+2.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +13.6% | +17.9% | +4.3 pp |
| 1 year | -5.8% | +23.1% | +28.9 pp |
| 3-year CAGR | +6.2% | +18.8% | +12.5 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 56.2M USD
- Year-over-year change
- -5.8%
- 4-year CAGR
- +7.4%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 56.2M | -5.8% |
| FY2024 | 2024-12-31 | 59.63M | +18.7% |
| FY2023 | 2023-12-31 | 50.23M | +7.2% |
| FY2022 | 2022-12-31 | 46.85M | +11.0% |
| FY2021 | 2021-12-31 | 42.21M | — |
Revenue vs competitors
How MASS compares with its peers on the latest reported figures
- MASS's LTM Mar 2026 revenue of $57.8M is the lowest of the 3 companies compared; the peer median is $4.74B.
- Its year-over-year change of +2.2% is the lowest of 3, against a peer median of +5.8%.
- Over three fiscal years its annual growth of +6.2% compares with a peer median of -0.2%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jul 2026 | $7.37B | +8.6% | +0.5% | |
| LTM Jun 2026 | $2.1B | +3.0% | -0.8% | |
| LTM Mar 2026 | $57.8M | +2.2% | +6.2% | |
| Peer median (excluding MASS) | $4.74B | +5.8% | -0.2% | |
Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 42.21M | 46.85M | 50.23M | 59.63M | 56.2M |
| Cost of Revenue | 18.97M | 20.83M | 24.91M | 29.71M | 29.4M |
| Gross Profit | 23.23M | 26.02M | 25.32M | 29.93M | 26.8M |
| Gross Margin | 55.0% | 55.5% | 50.4% | 50.2% | 47.7% |
| Research & Development | 13.07M | 17.53M | 21.9M | 25.5M | 13.8M |
| Selling, General & Admin | 32.24M | 43.88M | 0 | 0 | 37.18M |
| Operating Expenses | 45.3M | 61.41M | 68.08M | 106.64M | 50.98M |
| Depreciation & Amortization | 925K | 1.61M | 2.38M | 4.68M | 4.47M |
| EBITDA | (20.76M) | (31.82M) | (40.27M) | (43.88M) | (28.88M) |
| EBITDA Margin | -49.2% | -67.9% | -80.2% | -73.6% | -51.4% |
| Operating Income | (22.07M) | (35.38M) | (42.76M) | (76.72M) | (24.18M) |
| Operating Margin | -52.3% | -75.5% | -85.1% | -128.7% | -43.0% |
| Interest Income | 548K | 2.03M | 6.48M | 4.49M | 4.14M |
| Interest Expense | 486K | 129K | 201K | 0 | 0 |
| Other Income / Expenses | (100K) | 1.82M | 6.15M | 4.23M | (9.16M) |
| Income Before Tax | (22.17M) | (33.56M) | (36.61M) | (72.49M) | (33.34M) |
| Pre-Tax Margin | -52.5% | -71.6% | -72.9% | -121.6% | -59.3% |
| Income Tax Expense | 0 | 0 | (211K) | (282K) | (66K) |
| Net Income | (22.17M) | (33.56M) | (36.4M) | (72.21M) | (36.64M) |
| Net Margin | -52.5% | -71.6% | -72.5% | -121.1% | -65.2% |
| EPS (Basic) | (0.79) | (1.07) | (1.13) | (2.12) | 0.54 |
| EPS (Diluted) | (0.79) | (1.07) | (1.13) | (2.12) | 0.54 |
| Weighted Avg Shares | 27.96M | 31.49M | 32.21M | 34.08M | 36.22M |
| Weighted Avg Shares (Diluted) | 27.96M | 31.49M | 32.24M | 34.08M | 38.92M |
908 Devices Inc.
NASDAQ:MASS
Intrinsic Alpha fair value
Locked
Current Price
$9.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.